Triple HIV Antibody Trial

Are you…

  • 18 – 65 years of age?
  • Living with HIV?
  • Taking antiretroviral treatment (ART)?

Could an infusion of an investigational antibody product be a prevention/treatment of HIV?

This study is assessing the use of an infusion of three antibodies as an alternative treatment for people living with HIV. We want to see if these antibodies can control the virus during an interruption of your ART. Your participation would be for one year, and you would be compensated up to $1925 for expenses and travel associated with participation. Learn more

  • You may be compensated up to $1925 for expenses and travel associated with participation.
  • If you would like to be considered for participation, please complete the form at right.
  • We are available to discuss your concerns and answer your questions. You can call us at (617) 735-4610 or email us at cvvrtrials@bidmc.harvard.edu.